Filtros de búsqueda

Lista de obras de Peter Liljeström

A 6K-deletion variant of salmonid alphavirus is non-viable but can be rescued through RNA recombination.

artículo científico publicado en 2014

A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.

artículo científico publicado en 2014

A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens.

artículo científico publicado en 2000

Alphavirus expression vectors and their use as recombinant vaccines: a minireview.

artículo científico publicado en 1997

Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigen.

artículo científico publicado en 2015

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

artículo científico publicado en 2008

Aromatic interactions define the binding of the alphavirus spike to its nucleocapsid

scientific article published on 01 May 1996

Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus

artículo científico publicado en 2017

Budding of enveloped viruses from the plasma membrane.

artículo científico publicado en 1997

Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor.

artículo científico publicado en 2007

Comparison of the efficacy of early versus late viral proteins in vaccination against SIV

scientific article published on 01 July 2002

Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols

artículo científico publicado en 2002

DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model.

artículo científico publicado en 2004

De-novo transcriptome sequencing of a normalized cDNA pool from influenza infected ferrets.

artículo científico publicado en 2012

Delivery and expression of heterologous genes in mammalian cells using self-replicating alphavirus vectors.

artículo científico publicado en 2004

Distinct Immunogenicity and Efficacy of Poxvirus-based Vaccine Candidates against Ebola Virus expressing GP and VP40 Proteins

artículo científico publicado en 2018

EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium.

artículo científico publicado en 2008

Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles.

artículo científico publicado en 2005

Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara.

artículo científico publicado en 2001

Enhancing immune responses using suicidal DNA vaccines.

artículo científico publicado en 1998

Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C

artículo científico publicado en 2006

Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

artículo científico publicado en 1995

Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.

artículo científico publicado en 2006

Humoral responses against coimmunized protein antigen but not against alphavirus-encoded antigens require alpha/beta interferon signaling

artículo científico publicado en 2006

Immunotherapy with recombinant SFV-replicons expressing the P815A tumor antigen or IL-12 induces tumor regression.

artículo científico publicado en 2002

Intradermal Electroporation of RNA

artículo científico publicado en 2014

Intradermal electroporation of naked replicon RNA elicits strong immune responses

artículo científico publicado en 2012

Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations

artículo científico publicado en 2014

Live viral vectors: Semliki Forest virus.

artículo científico publicado en 2003

Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques.

artículo científico publicado en 2010

Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo.

artículo científico publicado en 2003

Modification of a salmonid alphavirus replicon vector for enhanced expression of heterologous antigens

artículo científico publicado en 2014

Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting

artículo científico publicado en 2005

MyD88 expression is required for efficient cross-presentation of viral antigens from infected cells.

artículo científico publicado en 2005

Non-viral amplification systems for gene transfer: vectors based on alphaviruses.

artículo científico publicado en 1999

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.

artículo científico publicado en 1997

Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV

artículo científico publicado en 2019

Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens

artículo científico publicado en 2018

Prime-boost immunization strategies against Chikungunya virus

artículo científico publicado en 2014

Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge

artículo científico publicado en 2004

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates

artículo científico publicado en 2006

Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge.

artículo científico publicado en 1999

Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response.

artículo científico publicado en 2001

Reversible Acid-Induced Inactivation of the Membrane Fusion Protein of Semliki Forest Virus

artículo científico publicado en 2005

Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines

artículo científico publicado en 2011

Role of the C-terminal tryptophan residue for the structure-function of the alphavirus capsid protein.

artículo científico publicado en 1998

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).

artículo científico publicado en 2011

Self-replicating alphavirus RNA vaccines.

artículo científico

Semliki Forest virus produced in the absence of the 6K protein has an altered spike structure as revealed by decreased membrane fusion capacity.

artículo científico publicado en 2004

Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems.

artículo científico publicado en 2001

Suppressors of Cleavage-Site Mutations in the p62 Envelope Protein of Semliki Forest Virus Reveal Dynamics in Spike Structure and Function

artículo científico publicado el 1 de abril de 1998

T-cell-mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challenge.

artículo científico publicado en 2004

The 6-kilodalton membrane protein of Semliki Forest virus is involved in the budding process

artículo científico publicado en 1995

Toll-like receptor 3 promotes cross-priming to virus-infected cells.

artículo científico publicado en 2005

Two-helper RNA system for production of recombinant Semliki forest virus particles.

artículo científico publicado en 1999

Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.

artículo científico publicado en 2000

Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens.

artículo científico publicado en 2004

Viral vectors for malaria vaccine development

artículo científico publicado en 2006